Benefit of COVID-19 vaccination accounting for potential risk compensation

Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities

(2021) John P.A. Ioannidis et al.   ENVIRONMENTAL RESEARCH

Applying principles of behaviour change to reduce SARS-CoV-2 transmission

(2020) Robert West et al.   Nature Human Behaviour

Is risk compensation threatening public health in the covid-19 pandemic?

(2020) Eleni Mantzari et al.   BMJ-British Medical Journal

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us

(2020) Peter Doshi   BMJ-British Medical Journal

Efficacy and safety of COVID-19 vaccines in older people

(2020) Roy L Soiza et al.   AGE AND AGEING

SARS-CoV-2 (COVID-19) superspreader events

(2020) Dasha Majra et al.   JOURNAL OF INFECTION

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

(2020) Alicia T. Widge et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research

(2016) Monica L. Kasting et al.   Human Vaccines & Immunotherapeutics

The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks

(2012) Thomas Obadia et al.   BMC Medical Informatics and Decision Making

The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: Examining the RV144 trial results

(2011) Kyeen M. Andersson et al.   VACCINE

The potential impact of RV144-like vaccines in rural South Africa: A study using the STDSIM microsimulation model

(2011) Jan A.C. Hontelez et al.   VACCINE